WO2005063227A1 - Process for producing triterpene composition - Google Patents
Process for producing triterpene composition Download PDFInfo
- Publication number
- WO2005063227A1 WO2005063227A1 PCT/JP2004/019428 JP2004019428W WO2005063227A1 WO 2005063227 A1 WO2005063227 A1 WO 2005063227A1 JP 2004019428 W JP2004019428 W JP 2004019428W WO 2005063227 A1 WO2005063227 A1 WO 2005063227A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- callus
- producing
- triterpene composition
- perilla
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Definitions
- the present invention relates to a method for producing a triterpene composition, a triterpene composition, and a callus for use in producing a triterpene composition.
- Triterpenes such as corosolic acid, tolmentic acid, and maslinic acid are known to be useful substances that exhibit pharmacological activities such as blood sugar lowering action, and are extracted as components from natural plants. Examples of obtaining these triterpenes have been reported so far.
- Non-Patent Document 1 As a plant containing corosolic acid, for example, banaba (Lagerstroemia speciosa) is known (for example, Non-Patent Document 1), and as a plant containing tormentetic acid, for example, Tigerella polyphyla (Tiarella polyphyla) ) Is known (for example, Non-Patent Document 2), and as a plant containing maslinic acid, for example, Olive (Olea europasea) is known (for example, Patent Document 1).
- banaba Laagerstroemia speciosa
- tormentetic acid for example, Tigerella polyphyla (Tiarella polyphyla)
- maslinic acid for example, Olive (Olea europasea) is known (for example, Patent Document 1).
- Patent document 1 International publication 03Z057224 pamphlet
- Non-Patent Document 1 "Pharmacology and Therapy", 1999, Vol. 27, No. 6, p. 1075— p. 1077
- Non-Patent Document 2 Archives of Pharmacal Research, Korea, 2002 , 25 volumes, No. 1, p. 57— p. 60
- triterpenes such as corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-3-oxo-l-ul-12-en-28-oic acid and maslinic acid can be chemically synthesized at low cost. There is no known method.
- an object of the present invention is to provide at least one triterpene selected from the group consisting of corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-3oxo-urose-12ene-28 euic acid and maslinic acid.
- Another object of the present invention is to provide a means for stably and efficiently supplying a triterpene composition containing the same.
- Callus culture is a technique for culturing calli induced by culturing parts of leaves, stems, roots, and the like cut out of a plant on a medium, and is used for basic research on biosynthesis of metabolites. May be
- the present inventors used banapa, vegetation, perilla, or guava as an original plant for inducing callus, and cultured the induced callus together with a specific plant hormone.
- the present inventors have found that specific triterpenes are produced with high efficiency in calli, and have completed the present invention.
- the method for producing a triterpene composition of the present invention is characterized in that a callus derived from banapa, vegetation, perilla or guano is cultured with indoleacetic acid and other plant hormones,
- This is a method for producing a triterpene composition containing at least one triterpene selected from the group consisting of corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-3oxourose-12-en-28 euic acid and maslinic acid. .
- a triterpene composition of the present invention it is preferable to subculture callus.
- a triterpene composition can be continuously obtained from the callus induced by Capana, such as banaba, without inducing another new virus.
- Calli can also induce leaf, seed, stem, shoot apex, root or germ cell forces. By inducing such calligraphy, it becomes possible to obtain a triterpene composition efficiently in a shorter period of time.
- the cultured callus contains maslinic acid, corosolic acid in an amount of 4 to 10 times the weight of maslinic acid, and tormentetic acid in an amount of 2 to 8 times the weight of maslinic acid. It is preferable to contain 1.5 to 4 times the amount of 2 ⁇ , 19 ⁇ -dihydroxy-3-oxo-1-urethane-12-28-ic acid!
- corosolic acid which is highly useful in terms of blood sugar lowering action, is highly purified. It is important that the ratio of corosolic acid to maslinic acid is high, to make it easier to obtain at a high degree.
- the present invention also provides a callus derived from banapa, vegetation, perilla, or guano and used for the above production method.
- the power of the present invention derived from vanapa, vegetation, perilla or guava is corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-13-oxo-lour —12-en-28-oic acid And a large amount of triterpenes such as maslinic acid.
- a triterpene composition comprising at least one can be provided. This triterpen composition can be used as a raw material for health foods, medicines, cosmetics and the like.
- the present invention further provides a triterpene of corosolic acid, tolmentic acid, 2a, 19 ⁇ -dihydroxy-3-oxo-urus-12-en-28-oic acid or maslinic acid from this triterpene composition. Is provided by isolating and purifying the compound. By applying this production method, a high-purity triterpene that can be used for pharmaceuticals and the like can be obtained with high efficiency.
- a triterpene composition containing at least one selected from the group consisting of carp can be stably supplied at a high efficiency.
- callus (undifferentiated cell mass derived from a plant cell) is induced from banapa, vegetation, perilla or guava.
- Banaba scientific name: Lager stroemia speciosa, Linn. Or Pers. Is a plant belonging to the family Araceae, and is used as a street ⁇ and its leaves are used as a traditional herbal medicine in the Philippines.
- Callus is induced by naturally growing power or artificially cultivated banana or vegetation. , Perilla or guava can be used. In order to efficiently obtain a triterpene composition in a short-term culture, it is more preferable to induce leaf, seed, stem, shoot apex, root or germ cell callus, and more preferably to induce leaf or seed force. In addition, calli may be induced from the prepared protoplasts with these site forces!
- Callus induction is performed by, for example, sterilizing a site such as a leaf from which a force such as a banaba is cut out with sodium hypochlorite, cutting the portion to an appropriate size with a scalpel, and transplanting the force into a medium. Cultivation methods can be adopted.
- the callus is preferably induced in a solid medium such as a Linsmeier-Skoog agar medium (hereinafter referred to as "LS agar medium”) which can be induced in a solid medium or a liquid medium.
- LS agar medium Linsmeier-Skoog agar medium
- plant hormones other than indoleacetic acid used in combination with indoleacetic acid include potato-inetin, 1-naphthaleneacetic acid, 6-benzylazidenine, and the like, and potato-inetin is particularly preferred.
- the callus is preferably cultured in a solid medium such as LS agar medium under aseptic conditions at 20-30 ° C in a dark place.
- Cultivated callus power [0026] Cultivated callus power [0026]
- the triterpene composition can be obtained directly, or a part of the cultured callus is transplanted to another new solid medium or liquid medium and cultured again, that is, from the callus subjected to subculture. A triterpene composition can also be obtained. By repeating subculture, a triterpene composition can be stably obtained over a long period of time.
- a part of the previously cultured callus may be used as it is, or a microplast may be prepared from a part of the cultured callus, and the microplast may be placed in a liquid medium. May be used for suspension culture.
- the conditions for subculture are as follows: Preferably, the conditions are the same as those described above.
- the culture period for one passage in the subculture is preferably 5 to 30 days. The subculture can be continued while renewing the generation as long as the production amount of the target triterpene in the callus is not significantly reduced.
- corosolic acid and tormentetic acid have great utility in terms of pharmacological activity and the like. Is preferably large. Specifically, maslinic acid, corosolic acid in an amount of 4 to 10 times the weight of maslinic acid, 2 to 6 times the amount of tolmentic acid, 1.5 to 4 times the amount of 2 ⁇ , 19 ⁇ -dihydroxy-l-oxo-unoleth-l-l-en-28-oitic acid.
- a method of quantifying the content of triterpene contained in the callus a method of analyzing components extracted from the cultured callus using methanol or the like by liquid chromatography and quantifying from the area of the obtained chromatogram is used. Can be suitably adopted.
- the extract obtained by extracting the cultured callus by using a known method is obtained by using corosolic acid, tonomenthetic acid, 2,19-dihydroxy-13-year-old quinone-unoleth-12-e.
- This is a triterpene composition containing a large amount of itic acid and maslinic acid.
- the triterpene composition can be used as a raw material for health foods or the like, or may be further purified to remove unnecessary components.
- Extraction from the cultured callus may be performed using raw callus after the culture, or may be performed using a callus that has been dried and crushed with force!
- the extraction solvent it is preferable to use a hydrophilic solvent such as water or an alcohol such as methanol or ethanol, and it is more preferable to use a heated water-alcohol mixed solvent.
- a dry callus crushed material (raw material) is mixed with ethanol or an aqueous ethanol solution (ethanol content of 50 to 80% by weight) 5 to 20 times, preferably 8 to 10 times the weight of the raw material.
- ethanol or an aqueous ethanol solution ethanol content of 50 to 80% by weight
- a method of refluxing and repeating this extraction 2-3 times can be suitably used.
- the triterpene composition When the amount of the triterpene composition is large, the triterpene composition is suspended in water and distributed to ether or hexane to remove low-polar components, and then the aqueous layer is treated with diaion -20. It is preferable to sequentially elute with water, methanol and acetone using column chromatography or the like, and to separate and purify the methanol-eluted fraction by silica gel column chromatography or the like.
- Corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-3-oxourus-12-en-28 euic acid or maslinic acid obtained by isolation and purification as described above are At least 90.0% by weight or more,
- it contains 98.0% by weight or more, even more preferably 99.9% by weight or more.
- the triterpene composition of the present invention is obtained by the above-described method, and is represented by corosolic acid represented by the following chemical formula (1), tolmentic acid represented by the following chemical formula (2), and represented by the following chemical formula (3) 2 OL, 19
- Triterpene compositions containing these triterpenes are known to have pharmacological activities such as blood glucose level lowering activity and antitumor activity, respectively, and can be used as raw materials for health foods and medicines.
- the highly pharmacologically active corosori Triterpene compositions containing carboxylic acid and tolmentic acid are particularly useful.
- LS agar medium with ⁇ ⁇ ⁇ of 5.8 was prepared in an Erlenmeyer flask by adding 10 ⁇ of indoleacetic acid and 10 ⁇ of force inetine as plant hormones, and sterilized banana leaves were placed on the LS agar. The callus was induced by culturing in a dark place at ° C.
- the induced calli were cultured and grown on an LS agar medium supplemented with 10 M of indole acetic acid and 10 M of force inetine for 3 weeks, and the grown calli were extracted by cold immersion in methanol.
- the triterpene content of the cultured calli was determined from the area of the peak corresponding to each triterpene in the chromatogram (ultraviolet absorptiometer, detection wavelength: 220 nm) obtained by performing chromatographic analysis.
- the content of triterpene in the original plant (banapa leaf) before callus induction was determined by the same method. The results are shown in Table 1.
- Ursolic acid 0.5 0.8 0.2 I .Q Oleanolic acid 0.4 0.3 0.1 0.5 Maslinic acid 1.6 1.0 0.2 1.0
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005516669A JPWO2005063227A1 (en) | 2003-12-26 | 2004-12-24 | Method for producing triterpene composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003433867 | 2003-12-26 | ||
JP2003-433867 | 2003-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005063227A1 true WO2005063227A1 (en) | 2005-07-14 |
Family
ID=34736535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/019428 WO2005063227A1 (en) | 2003-12-26 | 2004-12-24 | Process for producing triterpene composition |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2005063227A1 (en) |
KR (1) | KR20060123377A (en) |
WO (1) | WO2005063227A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009500013A (en) * | 2005-06-30 | 2009-01-08 | サムヤン ジェネックス コーポレイション | Method for producing corosolic acid by plant cell suspension culture |
JP6906830B1 (en) * | 2021-03-17 | 2021-07-21 | 株式会社東洋新薬 | Oral compositions, muscle-building compositions and anti-obesity compositions |
-
2004
- 2004-12-24 JP JP2005516669A patent/JPWO2005063227A1/en active Pending
- 2004-12-24 KR KR1020067012541A patent/KR20060123377A/en not_active Application Discontinuation
- 2004-12-24 WO PCT/JP2004/019428 patent/WO2005063227A1/en active Application Filing
Non-Patent Citations (5)
Title |
---|
BEGUM S. ET AL: "Triterpenoids from the leaves of Psidium guajava", PHYTOCHEMISTRY, vol. 61, no. 4, 2002, pages 399 - 403, XP004385769 * |
CHEN J.H. ET AL: "High-performance liquid chromatographic analysis of bioactive triterpenes in Perilla frutescens", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 32, no. 6, 21 August 2003 (2003-08-21), pages 1175 - 1179, XP002985090 * |
MURAKAMI C. ET AL: "Screening of plant constituents for effect on glucose transport activity on Ehrlich ascites tumor cells", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 41, no. 12, 1993, pages 2129 - 2131, XP000887220 * |
OSMAN A.M. ET AL: "Chemical examination of local plants. Part VII", EGYPTIAN JOURNAL OF CHEMISTRY, vol. 18, no. 2, 1975, pages 347 - 352, XP002985091 * |
TANIGUCHI S. ET AL: "Production of bioactive triterpenes by Eriobotrya japonica calli", PHYTOCHEMISTRY, vol. 59, no. 3, 2002, pages 315 - 323, XP004335024 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009500013A (en) * | 2005-06-30 | 2009-01-08 | サムヤン ジェネックス コーポレイション | Method for producing corosolic acid by plant cell suspension culture |
JP4769868B2 (en) * | 2005-06-30 | 2011-09-07 | サムヤン ジェネックス コーポレイション | Method for producing corosolic acid by plant cell suspension culture |
US8101411B2 (en) | 2005-06-30 | 2012-01-24 | Samyang Genex Corporation | Method for production of corosolic acid in suspension culture of plant cells |
JP6906830B1 (en) * | 2021-03-17 | 2021-07-21 | 株式会社東洋新薬 | Oral compositions, muscle-building compositions and anti-obesity compositions |
JP2022143483A (en) * | 2021-03-17 | 2022-10-03 | 株式会社東洋新薬 | Oral composition, muscle-building composition, and anti-obesity composition |
Also Published As
Publication number | Publication date |
---|---|
JPWO2005063227A1 (en) | 2007-07-19 |
KR20060123377A (en) | 2006-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4769868B2 (en) | Method for producing corosolic acid by plant cell suspension culture | |
Agarwal et al. | Micropropagation and validation of genetic homogeneity of Alhagi maurorum using SCoT, ISSR and RAPD markers | |
Oncina et al. | Bioproduction of diosgenin in callus cultures of Trigonella foenum-graecum L. | |
Luo et al. | Micropropagation of Dendrobium densiflorum Lindl. ex Wall. through protocorm-like bodies: effects of plant growth regulators and lanthanoids | |
JP5951491B2 (en) | Method for producing triptolide | |
WO2013106975A1 (en) | Preparation method, agricultural composition and applications of natural brassinolide analogs | |
KR20140122533A (en) | Mass propagation method for adventitious root of Astragali Radix containing the increased amount of Astragaloside IV | |
Kuzovkina et al. | Flavonoid production in transformed Scutellaria baicalensis roots and ways of its regulation | |
Khandy et al. | Obtaining and study of callus and suspension plant cell cultures of Tribulus terrestris L., a producer of steroidal glycosides | |
CN115851572A (en) | Method for increasing glabridin content in suspension culture cell of liquorice | |
Park et al. | Medicinal orchids: production of bioactive compounds and biomass | |
Cheng et al. | Production of flavonoids and terpene lactones from optimized Ginkgo biloba tissue culture | |
Jeong et al. | Effect of plant growth regulators on growth and biosynthesis of phenolic compounds in genetically transformed hairy roots of Panax ginseng CA Meyer | |
Ramawat et al. | Guggulsterone: a potent natural hypolipidemic agent from Commiphora wightii–problems, perseverance, and prospects | |
RU2360964C1 (en) | CULTURE OF ROOT STRAIN Hed th (Hedysarum theinum Krasnob) - PRODUCER OF ISOFLAVONS | |
JPH02231023A (en) | Raising seedling of genus pinelliae or genus angelic plant | |
US20050255569A1 (en) | Method for producing triterpene composition | |
WO2005063227A1 (en) | Process for producing triterpene composition | |
WO2007107803A2 (en) | Process and modified media for preparing callus- and cell suspension cultures of hypericum perforatum l. | |
Mangas et al. | Centella asiatica (L) Urban: An updated approach | |
JPH03262488A (en) | Production of podophyllotoxin compound | |
RU2296155C1 (en) | Strain of cultured cells of plants serratula coronata l | |
Singh et al. | Influence of growth regulators on the explants of Commiphora mukul (Hook. ex Stocks) Engl. under in vitro conditions | |
AU700033B2 (en) | Pilocarpin production process | |
KR101810412B1 (en) | Method for Culturing Adventitious Roots of Pseudolarix Amabilis in Media Containing Extracts of Brown Rices through Ultrasonic Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005516669 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067012541 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067012541 Country of ref document: KR |
|
122 | Ep: pct application non-entry in european phase |